Arseny D Moralev

29PUBLICATIONS
42CO-AUTHORS
Molecular targetsHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Apr 27, 2026
The Influence of TDP1 Inhibitor Usnic Acid Derivative OL9-116 on the Effects of Topotecan in Human Cells.

|Jan 28, 2026
Cyclophosphamide-Mediated Induction of Myeloid-Derived Suppressor Cells In Vivo: Kinetics of Accumulation, Immune Profile, and Immunomodulation by Oleanane-Type Triterpenoids.

Mona S Awad, Aleksandra V Sen'kova, Andrey V Markov

|Jan 10, 2026
A Combined Bioinformatics and Clinical Validation Study Identifies MDM2, FKBP5 and CTNNA1 as Diagnostic Gene Signatures for COPD in Peripheral Blood Mononuclear Cells.

Innokenty A Savin, Aleksandra V Sen'kova, Andrey V Markov

|Dec 30, 2025
Soloxolone N-3-(Dimethylamino)propylamide Suppresses Tumor Growth and Mitigates Doxorubicin-Induced Hepatotoxicity in RLS40 Lymphosarcoma-Bearing Mice.

Arseny D Moralev, Aleksandra V Sen'kova, Alina A Firsova

|Dec 30, 2025
Deciphering the Role of ADAMTS6 in the Epithelial-Mesenchymal Transition of Lung Adenocarcinoma Cells.

Kirill V Odarenko, Anastasiya M Matveeva, Grigory A Stepanov

|Dec 30, 2025
Reversing the Irreversible: miRNA-Targeting Mesyl Phosphoramidate Oligonucleotides Restore Sensitivity to Cisplatin and Doxorubicin of KB-8-5 Epidermoid Carcinoma Cells.

Svetlana Miroshnichenko, Rabia Demirel, Arseny Moralev

Pageof 5

Frequent Collaborators

25 joint publications

Marina Zenkova

10 joint publications

Aleksandra V Sen'kova

8 joint publications

Innokenty Savin

5 joint publications

Kirill V Odarenko